Search Results - Pecout, Solange

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Patients' preferences in therapeutic decision-making in digestive oncology: a single centre cross-sectional observational study

    Patients' preferences in therapeutic decision-making in digestive oncology: a single centre cross-sectional observational study by Nizet, Pierre, Grivel, Charlotte, Rabeau, Pauline, Pecout, Solange, Evin, Adrien, Labarthe, Sonia Prot, Navas, Dominique, Feuillet, Fanny, Bourdon, Marianne, Huon, Jean-François

    Published in Scientific reports
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study

    Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study by Nizet, Pierre, Touchefeu, Yann, Pecout, Solange, Cauchin, Estelle, Beaudouin, Eva, Mayol, Séverine, Fronteau, Clémentine, Huon, Jean-François

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The experience of being a caregiver of patients with digestive cancer, from patients and caregivers' perception: A mixed study

    The experience of being a caregiver of patients with digestive cancer, from patients and caregivers' perception: A mixed study by Grivel, Charlotte, Nizet, Pierre, Martin, Manon, Pécout, Solange, Lepeintre, Aurélie, Touchefeu, Yann, Prot-Labarthe, Sonia, Evin, Adrien, Huon, Jean-François

    Published in PloS one
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study

    Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase... by Kim, Stefano, Ghiringhelli, Francois, de la Fouchardière, Christelle, Evesque, Ludovic, Smith, Denis, Badet, Nicolas, Samalin, Emmanuelle, Lopez-Trabada Ataz, Daniel, Parzy, Aurelie, Desramé, Jérôme, Baba Hamed, Nabil, Buecher, Bruno, Tougeron, David, Bouché, Olivier, Dahan, Laetitia, Chibaudel, Benoist, El Hajbi, Farid, Mineur, Laurent, Dubreuil, Olivier, Ben Abdelghani, Meher, Pecout, Solange, Bibeau, Frederic, Herfs, Michael, Garcia, Marie-Line, Meurisse, Aurelia, Vernerey, Dewi, Taïeb, Julien, Borg, Christophe

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: